Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60.The vaccine candidates, made by Pfizer and GlaxoSmithKline, could become the world's first approved vaccines against the common virus.
#people #information #individuals #responsible #vaccination #administration #disease-control #requirements #effectiveness #pfizer-vaccine
[
add
]
[
|
|
...
]